`
[--[65.84.65.76]--]
METROPOLIS
Metropolis Healthcare Ltd

1750.55 -32.30 (-1.81%)

Related News for METROPOLIS

I-Sec upgrades Metropolis Healthcare to Buy, lowers target price to Rs 2,250

 11 Feb 2025 10:11 AM

ICICI Securities has upgraded Metropolis Healthcare to Buy, setting a target price of Rs 2,250. The company reported a net profit of Rs 31.47 crore for the latest quarter and a revenue growth of 10.87% year-on-year. Promoters hold a 49.4% stake, and ICICI expects strong earnings growth with an EBITDA margin of 24-27%.

METROPOLIS HEALTH: ACUTE PATIENT VOLUME WILL REBOUND IN Q4 || CO SEE A MAJOR OPPORTUNITY IN TIER 3-4 CITIES - CONCALL UPDATE

 05 Feb 2025 10:05 AM

METROPOLIS HEALTH: ACUTE PATIENT VOLUME WILL REBOUND IN Q4 || CO SEE A MAJOR OPPORTUNITY IN TIER 3-4 CITIES - CONCALL UPDATE

METROPOLIS HEALTH: CO MAINTAIN REVENUE GUIDANCE OF 13% AND 25%+ MARGIN IN Q4FY25 - CONCALL UPDATE

 05 Feb 2025 10:03 AM

METROPOLIS HEALTH: CO MAINTAIN REVENUE GUIDANCE OF 13% AND 25%+ MARGIN IN Q4FY25 - CONCALL UPDATE

Metropolis Q3 net profit rises 15.3% to Rs 31 crore, revenue up 11%

 04 Feb 2025 09:09 PM

Metropolis Healthcare on Tuesday reported a 15.3% year-on-year (YoY) rise in net profit to Rs 31 crore in Q3FY25 let my volume increase and better patient realisations.

METROPOLIS HEALTHCARE: Q3 EBITDA 720M RUPEES VS 648M (YOY) || Q3 EBITDA MARGIN 22.31% VS 22.28% (YOY)

 04 Feb 2025 06:23 PM

METROPOLIS HEALTHCARE: Q3 EBITDA 720M RUPEES VS 648M (YOY) || Q3 EBITDA MARGIN 22.31% VS 22.28% (YOY)

METROPOLIS HEALTHCARE: Q3 CONS NET PROFIT 314M RUPEES VS 271.5M (YOY) || Q3 REVENUE 3.23B RUPEES VS 2.9B (YOY)

 04 Feb 2025 06:23 PM

METROPOLIS HEALTHCARE: Q3 CONS NET PROFIT 314M RUPEES VS 271.5M (YOY) || Q3 REVENUE 3.23B RUPEES VS 2.9B (YOY)

METROPOLIS HEALTHCARE: US FDA APPROVED TEST KIT ARE AVAILABLE IN INDIA FOR HMPV - CNBCTV18

 06 Jan 2025 02:49 PM

METROPOLIS HEALTHCARE: US FDA APPROVED TEST KIT ARE AVAILABLE IN INDIA FOR HMPV - CNBCTV18

METROPOLIS HEALTHCARE: CO REVENUE GROWTH WAS DRIVEN BY PATIENT VOLUME GROWTH, TEST VOLUME GROWTH AND CHANGE IN PRODUCT MIX COUPLED WITH REALIZATION BENEFITS

 06 Jan 2025 01:11 PM

METROPOLIS HEALTHCARE: CO REVENUE GROWTH WAS DRIVEN BY PATIENT VOLUME GROWTH, TEST VOLUME GROWTH AND CHANGE IN PRODUCT MIX COUPLED WITH REALIZATION BENEFITS

METROPOLIS HEALTHCARE: CO'S REVENUES GREW BY APPROX. 11% ON A (YOY) BASIS

 06 Jan 2025 01:11 PM

METROPOLIS HEALTHCARE: CO'S REVENUES GREW BY APPROX. 11% ON A (YOY) BASIS

METROPOLIS HEALTHCARE: CO UPDATE REGARDING INCORPORATION OF UNIT NAMED METROPOLIS CLINICAL PATHOLOGY FOR DIAGNOSTIC SERVICES

 26 Dec 2024 07:30 AM

METROPOLIS HEALTHCARE: CO UPDATE REGARDING INCORPORATION OF UNIT NAMED METROPOLIS CLINICAL PATHOLOGY FOR DIAGNOSTIC SERVICES